Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Swearingen et al v. Santa Cruz Natural, Inc.
Case Number:
3:13-cv-04291
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
-
August 18, 2016
Calif. Cane Juice Suit Partially Thrown Out
A California federal judge on Wednesday doled out a partial win to Santa Cruz Natural in a class action accusing the company of concealing the presence of sugar in its sodas and juices by labeling them as containing evaporated cane juice, saying there’s no grounds for injunctive relief since the consumers don’t plan to buy the beverages again in the future.
-
July 02, 2014
Calif. Cane Juice Suit Revived, Stayed For FDA Review
A California federal judge on Tuesday revived a class action alleging Santa Cruz Natural Inc. concealed the presence of sugar in sodas and juices by labeling them as containing evaporated cane juice, granting the plaintiffs' motion to stay the litigation instead of dismissing it while the U.S. Food and Drug Administration considers the issue.
-
April 03, 2014
Cane Juice Labeling Suit Tossed Pending FDA Decision
A California federal judge on Wednesday dismissed a class action alleging Santa Cruz Natural Inc. veiled the presence of sugar in sodas and juices by labeling them as containing evaporated cane juice, saying the U.S. Food and Drug Administration would soon decide the case's dispositive issue.